Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Sciele Pharma Inc. (SCRX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SCRX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Even Fatter Yields for Pfizer; M&A Targets in the Sector
Mike Havrilla
•
Oct 17
•
3 Comments
Underdog Smallcaps: Potential Short Squeezes
J Clinton Hill
•
Sep 14
•
6 Comments
Eli Lilly's Brewing Battle With Bristol-Myers
Mike Huckman
•
Sep 07
•
Comment!
Has Lilly's Effient Been FDA Approved?
Mike Huckman
•
Sep 03
•
Comment!
Pharma Merger: Japan’s Shionogi Buys Atlanta's Sciele for $1.42 Billion
Ron Haruni
•
Sep 02
•
Comment!
Wall Street Breakfast: Must-Know News
SA Editor Rachael Granby
•
Sep 02
•
3 Comments
More articles on SCRX »
Latest Transcript
Sciele Pharma Inc. Q2 2008 Earnings Call Transcript
Wed July 30, 2008
More transcripts on SCRX »
Sentiment
What advice would you give to
SCRX?
123 characters left
What's your view of SCRX?
Make sure you include SCRX
140 characters left
|
Settings